Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 184,386
  • Shares Outstanding, K 32,123
  • Annual Sales, $ 34,290 K
  • Annual Income, $ -184,750 K
  • 60-Month Beta 1.93
  • Price/Sales 7.86
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.08
  • Number of Estimates 4
  • High Estimate -0.60
  • Low Estimate -1.39
  • Prior Year -2.60
  • Growth Rate Est. (year over year) +58.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.65 +57.18%
on 01/13/20
5.81 -1.20%
on 01/17/20
+1.75 (+43.86%)
since 12/17/19
3-Month
3.54 +62.15%
on 11/21/19
5.81 -1.20%
on 01/17/20
+1.11 (+23.97%)
since 10/17/19
52-Week
3.54 +62.15%
on 11/21/19
48.80 -88.24%
on 01/31/19
-36.26 (-86.33%)
since 01/17/19

Most Recent Stories

More News
Novavax Rises on Fast Track Designation to Influenza Vaccine

The FDA bestows a Fast Track Designation on Novavax's (NVAX) influenza vaccine candidate NanoFlu for adults aged 65 years and older. Shares rally.

SNY : 51.24 (+0.10%)
EXAS : 88.06 (-1.92%)
NVAX : 5.74 (+20.08%)
DNLI : 22.36 (+1.13%)
Best Penny Stocks To Trade Before Friday? 5 Names To Know

Every day we look for different stocks to trade. However, when it comes to penny stocks, we're very specific on certain criteria that need to be met before even considering adding it to your list. Mainly,...

ACB.TO : 2.77 (-0.72%)
NVAX : 5.74 (+20.08%)
REV : 24.02 (+0.38%)
Novavax Granted Fast Track Designation for NanoFlu in Older Adults

GAITHERSBURG, Md., Jan. 15, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...

NVAX : 5.74 (+20.08%)
Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...

JPM : 138.20 (+0.69%)
NVAX : 5.74 (+20.08%)
Watch for Novavax Inc to Potentially Rebound After Falling 1.44% Yesterday

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $4.07 to a high of $4.24. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $4.30 on...

NVAX : 5.74 (+20.08%)
Options Traders Expect Huge Moves in Novavax (NVAX) Stock

Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.

NVAX : 5.74 (+20.08%)
Novavax Inc Rises 18.78% on Heavy Volume: Watch For Potential Pullback

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $4.06 to a high of $4.88. Yesterday, the shares gained 18.8%, which took the trading range above the 3-day high of $4.15...

NVAX : 5.74 (+20.08%)
SmarTrend Watching for Potential Rebound in Shares of Novavax Inc After 2.27% Loss

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $3.54 to a high of $3.70. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $3.70 on...

NVAX : 5.74 (+20.08%)
Novavax: 3Q Earnings Snapshot

GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Thursday reported a loss of $18 million in its third quarter.

NVAX : 5.74 (+20.08%)
Novavax Reports Third Quarter 2019 Financial Results

- NanoFlu pivotal Phase 3 clinical trial initiated October 2019 with top-line data expected in the first quarter of 2020

NVAX : 5.74 (+20.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NVAX with:

Business Summary

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as...

See More

Key Turning Points

2nd Resistance Point 6.49
1st Resistance Point 6.11
Last Price 5.74
1st Support Level 5.06
2nd Support Level 4.39

See More

52-Week High 48.80
Fibonacci 61.8% 31.51
Fibonacci 50% 26.17
Fibonacci 38.2% 20.83
Last Price 5.74
52-Week Low 3.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar